Drug Price Transparency

Name: Drug Price Transparency
Creator: Newspaper Daily
License: United States government work; public domain unless the source record says otherwise.

Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records: 5,000
Last changed: 08/30/2026
Update schedule: 50 16 1 */3 * UTC
Coverage: 01/01/2024–01/01/2024
Method: Methodology

Record	Record Date	Vuga Group	Change Status	Recency Days	Public Significance Score
Humira(Cf) Pen Crohn'S-Uc-Hs	01/01/2024	Adalimumab	increased	972.23	100
Humira(Cf) Pen Crohn'S-Uc-Hs	01/01/2024	Adalimumab	increased	972.23	100
Humira(Cf) Pen Psor-Uv-Adol Hs	01/01/2024	Adalimumab	increased	972.23	100
Humira(Cf) Pen Psor-Uv-Adol Hs	01/01/2024	Adalimumab	increased	972.23	100
Humira(Cf) Pen	01/01/2024	Adalimumab	increased	972.23	100
Humira(Cf) Pen	01/01/2024	Adalimumab	increased	972.23	100
Humira(Cf) Pen	01/01/2024	Adalimumab	increased	972.23	100
Humira(Cf)	01/01/2024	Adalimumab	increased	972.23	100
Humira(Cf)	01/01/2024	Adalimumab	increased	972.23	100
Humira(Cf)	01/01/2024	Adalimumab	increased	972.23	100
Humira	01/01/2024	Adalimumab	increased	972.23	100
Humira	01/01/2024	Adalimumab	increased	972.23	100
Hyftor	01/01/2024	Sirolimus	increased	972.23	100
Hyftor	01/01/2024	Sirolimus	increased	972.23	100
Hyrimoz Pen	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz Pen	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf) Pen Crohn-Uc Start	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf) Pen Crohn-Uc Start	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf) Pen Psoriasis	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf) Pen Psoriasis	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf) Pen	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf) Pen	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf) Pen	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf)	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf)	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Hyrimoz(Cf)	01/01/2024	Adalimumab-Adaz	increased	972.23	100
Ibrance	01/01/2024	Palbociclib	increased	972.23	100
Ibrance	01/01/2024	Palbociclib	increased	972.23	100
Icatibant	01/01/2024	Icatibant Acetate	increased	972.23	100
Icatibant	01/01/2024	Icatibant Acetate	increased	972.23	100
Icatibant	01/01/2024	Icatibant Acetate	increased	972.23	100
Icatibant	01/01/2024	Icatibant Acetate	increased	972.23	100
Icatibant	01/01/2024	Icatibant Acetate	increased	972.23	100
Iclusig	01/01/2024	Ponatinib HCl	increased	972.23	100
Iclusig	01/01/2024	Ponatinib HCl	increased	972.23	100
Idacio(Cf) (2 Pack)	01/01/2024	Adalimumab-Aacf	increased	972.23	100
Idacio(Cf) (2 Pack)	01/01/2024	Adalimumab-Aacf	increased	972.23	100
Idacio(Cf) Pen (2 Pack)	01/01/2024	Adalimumab-Aacf	increased	972.23	100
Idacio(Cf) Pen (2 Pack)	01/01/2024	Adalimumab-Aacf	increased	972.23	100
Idhifa	01/01/2024	Enasidenib Mesylate	increased	972.23	100
Idhifa	01/01/2024	Enasidenib Mesylate	increased	972.23	100
Igalmi	01/01/2024	Dexmedetomidine HCl	increased	972.23	100
Igalmi	01/01/2024	Dexmedetomidine HCl	increased	972.23	100
Ilaris	01/01/2024	Canakinumab/PF	increased	972.23	100
Ilaris	01/01/2024	Canakinumab/PF	increased	972.23	100
Ilevro	01/01/2024	Nepafenac	increased	972.23	100
Ilevro	01/01/2024	Nepafenac	increased	972.23	100
Ilumya	01/01/2024	Tildrakizumab-Asmn	increased	972.23	100
Ilumya	01/01/2024	Tildrakizumab-Asmn	increased	972.23	100
Imbruvica	01/01/2024	Ibrutinib	increased	972.23	100